Renal Cancers Completed Phase 2 Trials for Everolimus (DB01590)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00331409Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney CancerTreatment
NCT00323739Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal CarcinomaTreatment
NCT00827359Biomarker Trial of Everolimus in Patients With Advanced Renal Cell CarcinomaTreatment